Glucose regulation of β-defensin-1 mRNA in human renal cells

Biochemical and Biophysical Research Communications

Volumn 353, Issue 2, 2007, Pages 318-323

  Malik, Afshan N ^a   Al Kafaji, Ghada ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Defensin 1; Diabetic nephropathy; Embryonic kidney cells; Human mesangial cells; Hyperglycemia; mRNA expression

Indexed keywords

BETA DEFENSIN 1; GLUCOSE; MESSENGER RNA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; KIDNEY CELL; MESANGIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

BETA-DEFENSINS; CELL LINE; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MESANGIAL CELLS; RNA, MESSENGER;

EID: 33845863416     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.037     Document Type: Article

References (31)

1. Page R.A., Morris C.A., Williams J.D., von Ruhland C.J., and Malik A.N. Isolation of diabetes-associated kidney genes using differential display. Biochem. Biophys. Res. Commun. 232 (1997) 49-53
2. Page R.A., and Malik A.N. Elevated levels of beta-defensin 1 mRNA in diabetic kidneys of GK rats". Biochem. Biophys. Res. Commun. 310 (2003) 513-521
3. Lehrer R.I., and Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 14 (2002) 96-102
4. Zhao C., Wang I., and Lehrer R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396 (1996) 319-322
5. Schonwetter B.S., Stolzenberg E.D., and Zasloff M.A. Epithelial antibiotics induced at sites of inflammation. Science 267 (1995) 1645-1648
6. Tarver A.P., Clark D.P., Diamond G., Russel J.P., Erdjument-Bromage H., Tempst P., Cohen K.S., Jones D.E., Sweeney R.W., Wines M., Hwang S., and Bevins C.L. Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 66 (1998) 1045-1056
7. Stolzenberg E.D., Anderson G.M., Ackermann M.R., Whitlock R.H., and Zasloff M. Epithelial antibiotic induced in states of disease. Proc. Natl. Acad. Sci. USA 94 (1997) 8686-8690
8. Goldman M.J., Anderson M., Stolzenberg E.D., Kari U.P., Zasloff M., and Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88 (1997) 553-560
9. Schroeder J.M., and Harder J. Antimicorbial skin peptides and proteins. Cell. Mol. Life Sci. 63 (2006) 469-486
10. Schnapp D., et al. Localisation of expression of huan beta defensin 1 in the pancreas and the kidney. J. Pathol. 186 (1998) 99-103
11. Valore E.V., Park C.H., Quayle A.J., Wiles Jr. K.R., McCray P.B., and Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101 (1998) 1633-1642
12. Lehman O.J., et al. Investigation of Beta defensin gene expression in the ocular anterior segment by semiquantitative RT-PCR. Br. J. Ophthalmol. 84 (2000) 523-526
13. Bensch K.W., Raida M., Magret H.-J., Schulz-Knappe P., and Forssmann W.-G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 368 (1995) 331-335
14. Zucht H.D., Grabowsky J., Schrader M., Liepke C., Jurgens M., Schulz-Knappe P., and Forssmann W.G. Human beta-defensin-1: a urinary peptide present in variant molecular forms and its putative functional implication. Eur. J. Med. Res. 3 (1998) 315-323
15. Sherman H., et al. Albumin and amino acids upregulate the expression of human beta defensin 1. Mol. Immunol. 43 (2006) 1617-1623
16. Donald C.D., et al. Cancer specific loss of beta defensin 1 in renal and prostatic carcinomas. Lab. Invest. 83 4 (2003) 501-505
17. Wheeler D.C., Chana R.S., Topley N., Petersen M.M., Davies M., and Williams J.D. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int. 45 6 (1994) 1628-1636
18. Walkley N.A., Demaine A.G., and Malik A.N. Cloning, structure and mRNA expression of human Cctg, which encodes the chaperonin subunit CCT gamma. Biochem. J. 313 Pt. 2 (1996) 381-389
19. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
20. Lee H.Y., Andalibi A., Webster P., Moon S.K., Teufert K., Kang S.H., Li J.D., Nagura M., Ganz T., and Lim D.J. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect. Dis. 4 (2004) 12
21. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11 (1993) 105-128
22. Schuetz A.N., et al. Molecular classification of renal tumours by gene expression profiling. J. Mol. Diagn. 7 2 (2005) 206
23. Chronell C. Human B-Defensin-1 and -2 expression in human Pilosebaceous Units: up-regulation in Acne Vulgaris lesions. J. Invest. Dermatol. 117 (2001) 1120-1125
24. Heishi M., et al. High-density oligonucleotide array analysis of mRNA transcripts in peripheral blood cells of severe atopic dermatitis patients. Int. Arch. Allergy Immunol. 129 1 (2002) 57-66
25. Wada H., et al. Extensive oligonucleotide microarray transcriptome analysis of the rat cerebral artery and arachnoid tissue. J. Atheroscler. Thromb. 9 5 (2002) 224-232
26. Schena F.P., and Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16 (2005) 30-33
27. Groop P., Forsblom C., and Thomas M.C. Mechanisms of disease: pathway selective insulin resistance and microvascular complications of diabetes. Nat. Clin. Pract. Endocrin. Metab. 1 (2005) 100-110
28. Brownlee M. The pathobiology of diabetic complications. Diabetes 54 (2005) 1615-1625
29. Nishikawa T., et al. Normalising mitochondrial and superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787-790
30. Lee H.B., et al. Reactive oxygen species regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. (2003) S241-S245
31. Liu H., et al. Amelioration of oxidant stress by the defensin lysozyme. Am. J. Physio. Endocrin. Metab. 290 (2006) E824-E833